Skip to main content

Animations

MJFF Publications

7221 - 7230 of 9117 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2023
  • 2019
  • 2024
  • 2023
  • 2024
  • 2024
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: Comparing machine learning and deep learning models to predict cognition progression in Parkinson's disease
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cts.70066
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The R1441C-Lrrk2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner in mice
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.adl1535
    Citation Count: 14
  • Summary Details
    OPEN
    Title: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson's Disease
    Journal Name: Journal of Clinical Neurology
    Publisher: Korean Neurological Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3988/jcn.2019.15.1.102
    Citation Count: 6
  • Summary Details
    OPEN
    Title: ePresentations
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.16338
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain
    Journal Name: Nature Nanotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41565-023-01419-x
    Citation Count: 126
  • Summary Details
    OPEN
    Title: An interpretable deep learning Bayesian optimized random forest framework for the diagnosis of Parkinson's disease in structural magnetic resonance images
    Journal Name: International Journal of Imaging Systems and Technology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ima.23106
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Outcome Selection for Research Studies in Movement Disorders
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.14087
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13890
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107054
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.